EU and Industry Join Forces to Invest €22 Billion in Research and Innovation

The European Commission, EU Member States and European industry will invest more than €22 billion over the next seven years in innovation for sectors that deliver high quality jobs. Most of the investment will go to five public-private partnerships in innovative medicines, aeronautics, bio-based industries, fuel cells and hydrogen, and electronics. These research partnerships will boost the competitiveness of EU industry in sectors that already provide more than 4 million jobs. They will also find solutions to major challenges for society that are not being solved quickly enough by the market alone, such as reducing carbon emissions or providing the next generation of antibiotics. The package also proposes to extend an initiative to pool research and innovation investments in Air Traffic Management (SESAR), in support of the Single European Sky.

José Manuel Barroso, President of the European Commission, said: "The EU must remain a leader in strategic global technology sectors that provide high quality jobs. This innovation investment package combines public and private funding to do just that. This is a perfect demonstration of the leverage effect of the EU budget for growth and jobs."

Overall, a proposed €8 billion investment from the next EU research and innovation programme, Horizon 2020, will secure around €10 billion from industry, and close to €4 billion from EU Member States.

European Commissioner for Research, Innovation and Science Máire Geoghegan-Quinn said: "These initiatives not only strengthen our economy, they are an investment in a better quality of life. Working together will enable us to tackle issues that no one company or country can deal with alone."

The five Public-Private Partnerships, called 'Joint Technology Initiatives' (JTIs), are:

  • Innovative Medicines 2 (IMI2): to develop next generation vaccines, medicines and treatments, such as new antibiotics
  • Fuel Cells and Hydrogen 2 (FCH2): to expand the use of clean and efficient technologies in transport, industry and energy
  • Clean Sky 2 (CS2): to develop cleaner, quieter aircraft with significantly less CO2 emissions
  • Bio-based Industries (BBI): to use renewable natural resources and innovative technologies for greener everyday products
  • Electronic Components and Systems (ECSEL): to boost Europe’s electronics manufacturing capabilities

The JTIs are open to a wide range of industries across Europe, including SMEs, and all types of research organisations can apply for funding. The Commission has developed the new initiatives in close partnership with industry, who in turn have committed substantial financial resources. Major changes have been introduced to address the criticisms that the current initiatives are overly complex and difficult to participate in.

The Innovative Medicines Initiative, Clean Sky and Fuel Cells and Hydrogen JTIs all currently exist, while the Electronics JTI will combine two current partnerships. The Bio-based Industries JTI is a new initiative. New legislative proposals are needed now to establish the initiatives under the next EU research and innovation programme, Horizon 2020, which is subject to approval by the European Parliament and Council.

The package also includes four public-public partnerships between the European Commission and EU Member States: new treatments against poverty-related diseases, measurement technologies for industrial competitiveness, support for high tech SMEs, and solutions for the elderly and disabled to live safely in their homes.

The Commission Communication accompanying the legislative proposals also sets out how the Commission intends to strengthen industrial engagement in Horizon 2020 through further public-private partnerships, such as in the areas of Green Cars, Energy Efficient Buildings, Factories of the Future, Sustainable Process Industries, Robotics and Photonics.

Most Popular Now

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

New Guidance for Ensuring AI Safety in C…

As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world clinical settings, according to an...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

Shape-Changing Device Helps Visually Imp…

Researchers from Imperial College London, working with the company MakeSense Technology and the charity Bravo Victor, have developed a shape-changing device called Shape that helps people with visual impairment navigate...

Bayer Acquires HiDoc Technologies and Ca…

Bayer is today announcing that it plans to acquire HiDoc Technologies GmbH in the first quarter of 2025 and to start commercialization of the digital health application, Cara Care®. Cara...

Almost All Leading AI Chatbots Show Sign…

Almost all leading large language models or "chatbots" show signs of mild cognitive impairment in tests widely used to spot early signs of dementia, finds a study in the Christmas...

AI-Based Chatbot Created for Bioimage An…

Scientists from Universidad Carlos III de Madrid (UC3M), together with a research team from Ericsson and the KTH Royal Institute of Technology in Sweden, have developed an artificial intelligence-based software...